{"nct_id":"NCT05623020","title":"A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, Lenalidomide or Elranatamab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-11-10","start_date_type":"ACTUAL","primary_completion_date":"2028-03-31","primary_completion_date_type":"ESTIMATED","completion_date":"2031-11-29","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PFE"]}